Diseases
Companies
Products
Productz
Mechanisms of Action
Sites
ASC11
/
Ascletis
Welcome,
Profile
Billing
Logout
Diseases
Trials
Trials
News
|||
|||||||
ASC11
/
Ascletis
New P1 trial:
Study to Evaluate Safety, Tolerability, PK and the Food Effect on PK of ASC11/RTV Tablets in Healthy Subjects
(clinicaltrials.gov) - Feb 8, 2023
P1
, N=72, Recruiting,
Sponsor: Ascletis Pharmaceuticals Co., Ltd.